- Active not recruitingPHASE3
A Study of Efficacy and Safety of Ianalumab Versus Placebo in Addition to Eltrombopag in Primary Immune Thrombocytopenia Patients Who Failed Steroids
This study is for adults with a blood condition called ITP who haven't improved with steroid treatment. It's testing a new drug called ianalumab, given with another drug called eltrombopag, to see if it can help keep blood platelet levels stable and safe for longer.
For: Primary Immune ThrombocytopeniaUnited States · Argentina · Austria - Ongoing, recruitingHuman Pharmacology (Phase I)- Bioequivalence Study
Bioequivalence of Eltrombopag 75 mg Film-Coated Tablets: A Single-Dose, Open-Label, Randomized, Two-Sequence, Two-Treatment, Two-Period Crossover Study in Healthy Subjects Under Fed Conditions.
This study is testing if two different versions of a medicine called Eltrombopag work the same way in healthy people. Eltrombopag is used for blood conditions like aplastic anemia and thrombocytopenia. Researchers are checking how the body absorbs and processes the medicine.
For: Aplastic anemia · ThrombocytopeniaPortugal - Ongoing, recruitingHuman Pharmacology (Phase I)- Bioequivalence Study
Bioequivalence of Eltrombopag 75 mg Film-Coated Tablets: A Single-Dose, Open-Label, Randomized, Two-Sequence, Two-Treatment, Two-Period Crossover Study in Healthy Subjects Under Fasting Conditions.
This study checks if a new version of Eltrombopag, a medicine for blood disorders like low platelet count, works the same way in the body as the existing one. Healthy people take a single dose, and doctors measure how the drug is absorbed and leaves the body.
For: Thrombocytopenia · Aplastic anemiaPortugal